announced today that it was awarded a Phase II contract from the Department
of Homeland Security. The goal of this project is to develop next-generation
molecular diagnostic assays for the rapid identification of biothreat
organisms, such as Bacillus anthracis. This contract will enable BioHelix
to further optimize and validate the HDA platform for use in the real-time
detection of both DNA and RNA pathogens.